JORIZA Trademark

Trademark Overview

On Monday, July 14, 2008, a trademark application was filed for JORIZA with the United States Patent and Trademark Office. The USPTO has given the JORIZA trademark a serial number of 77521598. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 21, 2017. This trademark is owned by Glaxo Group Limited. The JORIZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
joriza

General Information

Serial Number77521598
Word MarkJORIZA
Filing DateMonday, July 14, 2008
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 21, 2017
Registration Number3888450
Registration DateTuesday, December 14, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 28, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 21, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN

Trademark Events

Event DateEvent Description
Friday, July 21, 2017CANCELLED SEC. 8 (6-YR)
Monday, December 14, 2015COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 26, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 26, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 14, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, September 28, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 28, 2010PUBLISHED FOR OPPOSITION
Friday, August 20, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 20, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 19, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 19, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 16, 2010TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 10, 2010NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, May 10, 2010LETTER OF SUSPENSION E-MAILED
Monday, May 10, 2010SUSPENSION LETTER WRITTEN
Monday, May 3, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 30, 2010LIE CHECKED SUSP - TO ATTY FOR ACTION
Wednesday, October 28, 2009REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, October 26, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 30, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 30, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 27, 2009REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, April 27, 2009ASSIGNED TO LIE
Thursday, March 5, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 5, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 27, 2008NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, October 27, 2008LETTER OF SUSPENSION E-MAILED
Monday, October 27, 2008SUSPENSION LETTER WRITTEN
Tuesday, October 21, 2008ASSIGNED TO EXAMINER
Thursday, July 17, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

joriza pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic